Patient outcome in the Belgian medical need program on bevacizumab for recurrent glioblastoma.
Duerinck J, Clement PM, Bouttens F, Andre C, Neyns B, Staelens Y, Van Fraeyenhove F, Baurain JF, Luce S, D'hondt L, Joosens E, Specenier P, Verschaeve V, Filleul B, Vroman P, Stragier B, Rogiers A.
Duerinck J, et al.
J Neurol. 2015 Mar;262(3):742-51. doi: 10.1007/s00415-014-7633-z. Epub 2015 Jan 9.
J Neurol. 2015.
PMID: 25572162